JAK2/STAT3 pathway as a therapeutic target in ovarian cancers
Tomoyuki Yoshikawa(National Defense Medical College Hospital), Masashi Takano(National Defense Medical College)
Cited by 54
Related Papers
Uterine serous carcinoma
|Gynecologic Oncology|2021|158
Endometrial carcinosarcoma
|International Journal of Gynecological Cancer|2022|95